Repregan Capsule 75 mg (Pregabalin)

Adult dose

This medication is administered orally in divided doses twice daily, regardless of food intake. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose of 150 mg once daily may be increased to 300 mg daily after 3 to 7 days, and further increased to a maximum of 600 mg daily at 7-day intervals thereafter. - Central neuropathic pain: Starting dose is 150 mg once daily, may be increased to 300 mg daily after one week.

Child dose

The safety and efficacy data in children under the age of 12 and adolescents aged 12-17 is insufficient; therefore, administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so changes in mood or unusual signs of behavior should be carefully monitored during treatment. Do not use this medication if you have a hypersensitivity reaction to it or genetic issues such as lactose intolerance. Diabetic patients may need to adjust their blood sugar control medication doses due to weight gain, so caution is advised. If symptoms of angioedema occur, this medication should be stopped immediately, and elderly patients should be especially cautious during the initial phase of treatment due to increased risk of accidents from dizziness or drowsiness. Blurred vision or changes in vision may occur, so consult a doctor if these symptoms arise. Sudden discontinuation of this medication may result in withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so it must be tapered off gradually according to the physician's instructions. Patients with a history of drug abuse may be at higher risk of abusing this medication, so they should consult with healthcare professionals before use. Patients with heart disease or impaired kidney function should have their doses adjusted, and caution should be taken as combining this medication with opioid analgesics may increase the risk of central nervous system depression. During early pregnancy, there may be a risk of fetal malformations, so if you are pregnant or planning to become pregnant, consult a doctor before use, and breastfeeding should be stopped or the medication discontinued since it may pass into breast milk. Avoid dangerous activities such as driving or operating machinery until dizziness or drowsiness has resolved after taking this medication. In case of overdose, symptoms such as confusion, drowsiness, and depression may appear, and treatment such as hemodialysis may be required if necessary. This medication should be stored out of reach of children, and it is safer not to transfer it to another container. If skin rash or severe allergic reactions occur during treatment, stop taking the medication immediately and inform healthcare professionals.

Serious side effects

Hives, severe swelling (edema), angioedema, facial swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash accompanied by high fever, blisters, skin shedding, pain in mucous membranes of mouth/eyes, Stevens-Johnson syndrome, toxic epidermal necrolysis, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory complications with cough and fever, respiratory depression, breathing problems, yellowing of the skin or eyes (jaundice)

Mild side effects

• Dizziness
• drowsiness
• confusion
• disturbance in spatial orientation
• excitability
• depression
• feelings of well-being
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, it is recommended to keep the medication in a cool place between 15 to 30 degrees Celsius.

Appearance

Hard capsules with an upper reddish-brown and a lower white color containing a white powder that is white or pale yellow.

Package unit

30 capsules/bottle, 60 capsules/bottle